Works by Obata, Yoshiyuki

Results: 8

Imeglimin exerts favorable effects on pancreatic β-cells by improving morphology in mitochondria and increasing the number of insulin granules.

Published in:

Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-17657-3

By:

Sanada, Junpei;
Obata, Atsushi;
Fushimi, Yoshiro;
Kimura, Tomohiko;
Shimoda, Masashi;
Ikeda, Tomoko;
Nogami, Yuka;
Obata, Yoshiyuki;
Yamasaki, Yuki;
Nakanishi, Shuhei;
Mune, Tomoatsu;
Kaku, Kohei;
Kaneto, Hideaki

Publication type:

Article

Comprehensive Search for GPCR Compounds which Can Enhance MafA and/or PDX-1 Expression Levels Using a Small Molecule Compound Library.

Published in:

Journal of Diabetes Research, 2023, p. 1, doi. 10.1155/2023/8803172

By:

Kaneto, Hideaki;
Obata, Atsushi;
Shimoda, Masashi;
Kimura, Tomohiko;
Obata, Yoshiyuki;
Ikeda, Tomoko;
Moriuchi, Saeko;
Nakanishi, Shuhei;
Mune, Tomoatsu;
Kaku, Kohei

Publication type:

Article

Correction to: Vascular endothelial PDPK1 plays a pivotal role in the maintenance of pancreatic beta cell mass and function in adult male mice.

Published in:

2019

By:

Obata, Atsushi;
Kimura, Tomohiko;
Obata, Yoshiyuki;
Shimoda, Masashi;
Kinoshita, Tomoe;
Kohara, Kenji;
Okauchi, Seizo;
Hirukawa, Hidenori;
Kamei, Shinji;
Nakanishi, Shuhei;
Mune, Tomoatsu;
Kaku, Kohei;
Kaneto, Hideaki

Publication type:

Correction Notice

Vascular endothelial PDPK1 plays a pivotal role in the maintenance of pancreatic beta cell mass and function in adult male mice.

Published in:

Diabetologia, 2019, v. 62, n. 7, p. 1225, doi. 10.1007/s00125-019-4878-1

By:

Obata, Atsushi;
Kimura, Tomohiko;
Obata, Yoshiyuki;
Shimoda, Masashi;
Kinoshita, Tomoe;
Kohara, Kenji;
Okauchi, Seizo;
Hirukawa, Hidenori;
Kamei, Shinji;
Nakanishi, Shuhei;
Mune, Tomoatsu;
Kaku, Kohei;
Kaneto, Hideaki

Publication type:

Article

Dulaglutide exerts beneficial anti atherosclerotic effects in ApoE knockout mice with diabetes: the earlier, the better.

Published in:

Scientific Reports, 2021, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-80894-x

By:

Sanada, Junpei;
Obata, Atsushi;
Obata, Yoshiyuki;
Fushimi, Yoshiro;
Shimoda, Masashi;
Kohara, Kenji;
Nakanishi, Shuhei;
Mune, Tomoatsu;
Kaku, Kohei;
Kaneto, Hideaki

Publication type:

Article

Early combination therapy of empagliflozin and linagliptin exerts beneficial effects on pancreatic β cells in diabetic db/db mice.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-94896-w

By:

Fushimi, Yoshiro;
Obata, Atsushi;
Sanada, Junpei;
Nogami, Yuka;
Ikeda, Tomoko;
Yamasaki, Yuki;
Obata, Yoshiyuki;
Shimoda, Masashi;
Nakanishi, Shuhei;
Mune, Tomoatsu;
Kaku, Kohei;
Kaneto, Hideaki

Publication type:

Article

1435-P: Dulaglutide Exerts More Beneficial Antiatherosclerotic Effects in Early Phase of Diabetes than in Late Phase in ApoE Knockout Mice with Diabetes.

Published in:

Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1435-P

By:

SANADA, JUNPEI;
OBATA, ATSUSHI;
OBATA, YOSHIYUKI;
FUSHIMI, YOSHIRO;
IKEDA, TOMOKO;
NOGAMI, YUKA;
SHIMODA, MASASHI;
NAKANISHI, SHUHEI;
MUNE, TOMOATSU;
KAKU, KOHEI;
KANETO, HIDEAKI

Publication type:

Article

2054-P: Combination of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor and Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor Substantially Protects Pancreatic ß-Cells Especially in Early Phase of Diabetes Rather than Advanced Phase.

Published in:

Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-2054-P

By:

FUSHIMI, YOSHIRO;
OBATA, ATSUSHI;
SANADA, JUNPEI;
NOGAMI, YUKA;
IKEDA, TOMOKO;
OBATA, YOSHIYUKI;
SHIMODA, MASASHI;
NAKANISHI, SHUHEI;
MUNE, TOMOATSU;
KAKU, KOHEI;
KANETO, HIDEAKI

Publication type:

Article